Back to Search Start Over

Molecular and clinical spectra of FBXL4 deficiency.

Authors :
El-Hattab AW
Dai H
Almannai M
Wang J
Faqeih EA
Al Asmari A
Saleh MAM
Elamin MAO
Alfadhel M
Alkuraya FS
Hashem M
Aldosary MS
Almass R
Almutairi FB
Alsagob M
Al-Owain M
Al-Sharfa S
Al-Hassnan ZN
Rahbeeni Z
Al-Muhaizea MA
Makhseed N
Foskett GK
Stevenson DA
Gomez-Ospina N
Lee C
Boles RG
Schrier Vergano SA
Wortmann SB
Sperl W
Opladen T
Hoffmann GF
Hempel M
Prokisch H
Alhaddad B
Mayr JA
Chan W
Kaya N
Wong LC
Source :
Human mutation [Hum Mutat] 2017 Dec; Vol. 38 (12), pp. 1649-1659. Date of Electronic Publication: 2017 Oct 06.
Publication Year :
2017

Abstract

F-box and leucine-rich repeat protein 4 (FBXL4) is a mitochondrial protein whose exact function is not yet known. However, cellular studies have suggested that it plays significant roles in mitochondrial bioenergetics, mitochondrial DNA (mtDNA) maintenance, and mitochondrial dynamics. Biallelic pathogenic variants in FBXL4 are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia. Other features are feeding difficulties, growth failure, microcephaly, hyperammonemia, seizures, hypertrophic cardiomyopathy, elevated liver transaminases, recurrent infections, variable distinctive facial features, white matter abnormalities and cerebral atrophy found in neuroimaging, combined deficiencies of multiple electron transport complexes, and mtDNA depletion. Since its initial description in 2013, 36 different pathogenic variants in FBXL4 were reported in 50 affected individuals. In this report, we present 37 additional affected individuals and 11 previously unreported pathogenic variants. We summarize the clinical features of all 87 individuals with FBXL4-related mtDNA maintenance defect, review FBXL4 structure and function, map the 47 pathogenic variants onto the gene structure to assess the variants distribution, and investigate the genotype-phenotype correlation. Finally, we provide future directions to understand the disease mechanism and identify treatment strategies.<br /> (© 2017 Wiley Periodicals, Inc.)

Details

Language :
English
ISSN :
1098-1004
Volume :
38
Issue :
12
Database :
MEDLINE
Journal :
Human mutation
Publication Type :
Academic Journal
Accession number :
28940506
Full Text :
https://doi.org/10.1002/humu.23341